EFPIA Disclosure Code: Introduction

This area of the website was created by Zambon in full compliance with pharma.be Code of Deontology, the pharmaceutical industry association to which our company belongs.

The Code of Deontology has been agreed and voluntarily adopted by the pharmaceutical industry in compliance with the statutory rules and regulations of the Codes of Practice of the European and International Federations of the Pharmaceutical Industry and Associations (EFPIA and IFPMA), which are aimed at regulating the relationships between the industry and healthcare and scientific organisations and assocations.

Like all companies belonging to pharma.be, Zambon has been involved in the «Disclosure» project since 2015 with the aim of implementing the EFPIA Disclosure Code on Transfers of Value.

Specifically, the Disclosure Code requires that all transfers of value between the pharmaceutical industry, healthcare professionals and healthcare organisations be published on a yearly basis, with reporting starting in 2016.

As such, Zambon has prepared a table summarizing all transfers of value together with a brief itemised description as required by the provisions of EFPIA.

The Table with Transfers of Value is published in the Belgian Central and Public Platform.

What are transfers of value?

Transfers of value are payments of a financial nature to:

  • Healthcare professionals or organizations in relation to research and non clinical, clinical or non-interventional development
  • Healthtcare organizations in relation to donations and grants (contributions to costs for scientific events and fees for services and consultancy)
  • Healthcare professionals in relation to contribution to scientific events and fees for services and consultancy

How can the full autonomy of Healthcare Professionals be ensured?

It is essential to maintain a continuous dialogue and discussion between pharmaceutical companies and Healthcare Professionals for the development of medicines and our collective wellbeing.

These relationships must be managed in a manner that the physicians can maintain their prescribing autonomy.
Disclosure of financial payments made to Healthcare Professionals and organisations will avoid any misunderstandings about physician autonomy.

Respect for privacy

Because the reporting of the transfer of value amounts received by individual Healthcare Professionals involves the publication of their personal information, Zambon has left the decision entirely to the Healthcare Professional whether to authorise or deny the publication of transfers of value made to them.

Publication of values

This site contains a table that indicates the first and last name of the Healthcare Professional and the exact amount of the financial payments received only if the Healthcare Professional has authorised publication. The table also reports amounts paid to Healthcare Organisations.

If a Healthcare Professional denies publication, the transfer of value amounts made to them will be included in the aggregate value, in other words in the total amount of values paid by Zambon.

Indirect transfers

It should be noted that not all transfers of value published on a named basis – upon authorisation of the Healthcare Professional – have been materially collected by the Healthcare Professional. The company has very often paid the corresponding amount indirectly and not to the Healthcare Professional, for example to an agency to cover the travel costs for the Healthcare Professional to attend an educational meeting deemed useful for their profession.

Zambon Belgium extends their thanks

Zambon Belgium extends its thanks to those Healthcare Professionals who have authorised the publication of transfers of value on a named basis that occurred during 2015.

See the methodological note